Neutralizing Activity of SARS-CoV-2 Antibodies in Patients with COVID-19 and Vaccinated Individuals.
Tatjana Vilibić-ČavlekVladimir StevanovicSnjezana KovacEma BorkoMaja BogdanicGorana MileticZeljka HruskarThomas FerencIvona CoricMateja Vujica FerencLjiljana MilasincicLjiljana AntolasicLjubo BarbicPublished in: Antibodies (Basel, Switzerland) (2023)
The cross-immunity to SARS-CoV-2 is lowest for the Omicron variant compared to the Alpha/Delta variants.